Rn Pharmacology Online Practice A Questions And Correct Verified Answers

RN PHARMACOLOGY ONLINE PRACTICE
A QUESTIONS AND CORRECT VERIFIED
ANSWERS
AA2nurseA2isA2preparingA2toA2administerA2medicationA2toA2aA2clientA2whoA2hasA2gout.A2The
A2nurseA2discoversA2thatA2anA2errorA2wasA2madeA2duringA2theA2previousA2shiftA2andA2theA2
clientA2receivedA2atenololA2insteadA2ofA2allopurinol.A2WhichA2ofA2theA2followingA2actionsA2s
houldA2theA2nurseA2takeA2first?
A.A2obtainA2theA2client'sA2bloodA2pressure
B.A2contactA2theA2client'sA2provider
C.A2informA2theA2chargeA2nurse
D.A2completeA2anA2incidentA2reportA2-A2Ans--A.A2obtainA2theA2client'sA2bloodA2pressure
WHENA2USINGA2THEA2NURRSINGA2PROCESS,A2THEA2FIRSTA2ACTIONA2THEA2NURS
EA2SHOULDA2TAKEA2TOA2PREVENTA2INJURYA2TOA2THEA2CLIENTSA2ISA2TOA2ASSESS
A2THEA2CLIENTA2FORA2ADVERSEA2EFFECTSA2OFA2ATENOLOL,A2SUCHA2ASA2HYPOT
ENSION

AA2nurseA2isA2teachingA2aA2clientA2aboutA2cyclobenzaprine.A2WhichA2ofA2theA2followingA2cli
entA2statementsA2shouldA2indicateA2toA2theA2nurseA2thatA2theA2teachingA2isA2effective?
A.A2"IA2willA2haveA2increasedA2salivaA2production"
B.A2"IA2willA2continueA2takingA2theA2educationA2beforeA2discontinuingA2it"
C.A2"IA2willA2taperA2offA2theA2medicationA2beforeA2discontinuingA2it"
D.A2"IA2willA2reportA2anyA2urinaryA2incontinence"A2-A2Ans--
C.A2"IA2willA2taperA2offA2theA2medicationA2beforeA2discontinuingA2it"
THEA2CLIENTA2SHOULDA2TAPERA2OFFA2CYCLOBENZAPRINEA2BEFOREA2DISCONTI
NUINGA2ITA2TOA2PREVENTA2ABSTINENCEA2SYNDROMEA2ORA2REBOUNDA2INSOMNI
A

AA2nurseA2isA2assessingA2aA2clientA21A2hrA2afterA2administeringA2morphineA2forA2pain.A2Th
eA2nurseA2shouldA2identifyA2whichA2ofA2theA2followingA2findingsA2asA2theA2bestA2indicationA
2thatA2theA2morphineA2hasA2beenA2effective?
A.A2theA2client'sA2vitalA2signsA2areA2withinA2normalA2limits
B.A2theA2clientA2hasA2notA2requestedA2additionalA2medication
C.A2theA2clientA2isA2restingA2comfortablyA2withA2eyesA2closed
D.A2theA2clientA2ratesA2painA2asA23A2onA2aA2scaleA2fromA20A2toA210A2-A2Ans--
D.A2theA2clientA2ratesA2painA2asA23A2onA2aA2scaleA2fromA20A2toA210
THEA2CLIENT'SA2DESCRIPTIONA2OFA2THEA2PAINA2ISA2THEA2MOSTA2ACCURATEA2AS
SESSMENTA2OFA2PAIN

AA2nurseA2isA2assessingA2aA2clientA2afterA2administeringA2aA2secondA2doseA2ofA2cefazolinA
2IV.A2TheA2nurseA2notesA2theA2clientA2hasA2anxiety,A2hypotension,A2andA2dyspnea.A2Whic
hA2ofA2theA2followingA2medicationsA2shouldA2theA2nurseA2administerA2first?
A.A2diphenhydramine
B.A2albuterolA2inhaler

,C.A2epinephrine
D.A2prednisoneA2-A2Ans--C.A2epinephrine
ACCORDINGA2TA2EVIDENCE-
BASEDA2PRACTICE,A2THEA2NURSEA2SHOULDA2ADMINISTERA2EPINEPHRINEA2FIRS
TA2TOA2INDUCEA2VASCOCONSTRICTIONA2ANDA2BRONCHODILATIONA2DURINGA2A
NAPHYLAXIS

AA2nurseA2isA2providingA2teachingA2toA2aA2clientA2whoA2isA2beginA2takingA2oxybutyninA2forA
2urinaryA2incontinence.A2WhichA2ofA2theA2followingA2adverseA2effectsA2shouldA2theA2nurse
A2includeA2inA2theA2teaching?
A.A2dryA2mouth
B.A2tinnitus
C.A2blurredA2vision
D.A2bradycardia
E.A2dryA2eyesA2-A2Ans--A.A2dryA2mouth
C.A2blurredA2vision
E.A2dryA2eyes

AA2nurseA2isA2preparingA2toA2administerA2POA2sodiumA2polystyreneA2sulfonateA2toA2aA2clie
ntA2whoA2hasA2hyperkalemia.A2WhichA2ofA2theA2followingA2actionsA2shouldA2theA2nurseA2pl
anA2toA2take?
A.A2holdA2theA2client'sA2otherA2oralA2medicationsA2forA28A2hrA2postA2administration
B.A2informA2theA2clientA2thatA2thisA2medicationA2canA2turnA2stoolA2aA2lightA2tanA2color
C.A2keepA2theA2client'sA2solutionA2inA2theA2refrigeratorA2forA2upA2toA272A2hr
D.A2monitorA2theA2clientA2forA2constipationA2-A2Ans--
D.A2monitorA2theA2clientA2forA2constipation
THEA2NURSEA2SHOULDA2MONITORA2THEA2CLIENTA2FORA2THEA2ADVERSEA2EFFEC
TA2OFA2CONSTIPATIONA2ANDA2REPORTA2ITA2TOA2THEA2PROVIDERA2BECAUSEA2THI
SA2CANA2LEADA2TOA2FECALA2IMPACTION

AA2nurseA2isA2preparingA2toA2administerA2heparinA2subcutaneouslyA2toA2aA2client.A2WhichA
2ofA2theA2followingA2actionsA2shouldA2theA2nurseA2planA2toA2take?
A.A2administerA2theA2medicationA2outsideA2theA25-cmA2(2-in)A2radiusA2ofA2theA2umbilicus
B.A2aspirateA2forA2bloodA2returnA2beforeA2injecting
C.A2rubA2vigorouslyA2afterA2theA2injectionA2toA2promoteA2absorption
D.A2placeA2aA2pressureA2dressingA2onA2theA2injectionA2siteA2toA2preventA2bleedingA2-
A2Ans--A.A2administerA2theA2medicationA2outsideA2theA25-cmA2(2-
in)A2radiusA2ofA2theA2umbilicus
THEA2NURSEA2SHOULDA2ADMINISTERA2THEA2HEPARINA2BYA2SUBCUTANEOUSA2IN
JECTIONA2TOA2THEA2ABDOMENA2INA2ANA2AREAA2THATA2ISA2ABOVEA2THEA2ILIACA2C
RESTA2ANDA2ATA2LEASTA25A2CMA2(2A2IN)A2AWAYA2FROMA2THEA2UMBILICUS.

AA2nurseA2isA2teachingA2aA2clientA2whoA2isA2toA2beginA2takingA2tamoxifenA2forA2theA2treatm
entA2ofA2breastA2cancer.A2WhichA2ofA2theA2followingA2adverseA2effectsA2shouldA2theA2nurs
eA2includeA2inA2theA2teaching?
A.A2hotA2flashes

, B.A2urinaryA2retention
C.A2constipation
D.A2bradycardiaA2-A2Ans--A.A2hotA2flashes
THEA2ESTROGENA2RECEPTORA2BLOCKINGA2ACTIONA2OFA2TAMOXIFENA2COMMON
LYA2RESULTSA2INA2THEA2ADVERSEA2EFFECTA2OFA2HOTA2FLASHES

AA2nurseA2isA2reviewingA2theA2laboratoryA2resultsA2ofA2aA2clientA2whoA2isA2takingA2digoxinA2
forA2heartA2failure.A2WhichA2ofA2theA2followingA2resultA2shouldA2theA2nurseA2reportA2toA2the
A2provider?
A.A2calciumA2levelA29.2A2mg/dL
B.A2magnesiumA2levelA21.6A2mEq/L
C.A2digoxinA2levelA21.1A2mg/mL
D.A2potassiumA2levelA22.8A2mEq/LA2-A2Ans--D.A2potassiumA2levelA22.8A2mEq/L
AA2POTASSIUMA2LEVELA2OFA22.8A2mEq/
LA2ISA2BELOWA2THEA2EXPECTEDA2REFERENCEA2RANGEA2OFA23.5A2TOA25A2mEq/
L.A2THEA2NURSEA2SHOULDA2NOTIFYA2THEA2PROVIDERA2IFA2AA2CLIENTA2HASA2HYP
OKALEMIAA2PRIORA2TOA2ADMINISTRATIONA2OFA2DIGOXINA2DUEA2TOA2INCREASED
A2RISKA2OFA2DEVELOPINGA2DIGOXINA2TOXICITYA2ANDA2CARDIACA2DYSRHYTHMIA
S

AA2nurseA2isA2providingA2teachingA2toA2aA2clientA2whoA2hasA2pepticA2ulcerA2diseaseA2andA2
isA2toA2startA2aA2newA2prescriptionA2forA2sucralfate.A2WhichA2ofA2theA2followingA2actionsA2o
fA2sucralfateA2shouldA2theA2nurseA2includeA2inA2theA2teaching?
A.A2decreaseA2stomachA2acidA2secretion
B.A2neutralizesA2acidsA2inA2theA2stomach
C.A2formsA2aA2protectiveA2barrierA2overA2ulcers
D.A2treatsA2ulcersA2byA2eradicatingA2H.A2pyloriA2-A2Ans--
C.A2formsA2aA2protectiveA2barrierA2overA2ulcers
SECRETIONSA2BYA2THEA2PARIETALA2ANDA2CHIEFA2CELLS,A2HYDROCHLORICA2ACI
DA2ANDA2PEPSIN,A2CANA2FURTHERA2IRRITATEA2THEA2ULCERATEDA2AREAS.A2SUC
RALFATE,A2AA2MUCOSALA2PROTECTANT,A2FORMSA2AA2GEL-
LIKEA2SUBSTANCEA2THATA2COATSA2THEA2ULCER,A2CREATINGA2AA2BARRIERA2TOA2
HYDROCHLOICA2ACIDA2ANDA2PEPSIN

AA2nurseA2isA2assessingA2aA2clientA2whoA2hasA2myastheniaA2gravisA2andA2isA2takingA2neos
tigmine.A2WhichA2ofA2theA2followingA2findingsA2shouldA2indicateA2toA2theA2nurseA2thatA2theA
2clientA2isA2experiencingA2anA2adverseA2effect?
A.A2tachycardia
B.A2oliguria
C.A2xerostomia
D.A2miosisA2-A2Ans--D.A2miosis
MIOSIS,A2WHICHA2ISA2PUPILLARYA2CONSTRICTION,A2ISA2AA2COMMONA2ADVERSEA2
EFFECTA2OFA2NEOSTIGMINEA2DUEA2TOA2THEA2EXCESSIVEA2MUSCARINICA2STIMU
LATIONA2THATA2CAUSESA2DIFFICULTYA2WITHA2VISUALA2ACCOMMODATION